#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13558	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2188	616.9	0	.	n	.	0	A69G	SNP	69	69	A	404	404	G	791	G,A	726,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13558	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2188	616.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1785	1785	T	809	T,C	724,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13558	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2188	616.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1519	1519	C	811	C	766	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25314	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3707	681.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1749	1749	A	849	A	789	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25314	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3707	681.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2383	2383	C	827	C	776	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25314	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3707	681.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2457	2457	A	774	A	721	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25314	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3707	681.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3009	3009	C	780	C,T	720,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	1868	folP	852	852	100.0	folP.l15.c4.ctg.1	1559	119.5	1	SNP	p	R228S	0	.	.	682	684	CGC	1025	1027	CGC	190;191;189	C;G;C	175;179;174	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4534	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	133.4	1	SNP	p	S91F	0	.	.	271	273	TCC	532	534	TCC	154;154;154	T;C;C	136;139;138	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4534	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	133.4	1	SNP	p	D95N	0	.	.	283	285	GAC	544	546	GAC	151;149;148	G;A;C	137;135;136	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4534	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	133.4	1	SNP	p	D95G	0	.	.	283	285	GAC	544	546	GAC	151;149;148	G;A;C	137;135;136	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1514	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1228	122.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	434	436	ACC	189;188;189	A,G;C;C	178,1;177;179	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1514	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1228	122.5	1	SNP	p	G45D	1	G45D	NONSYN	133	135	GGC	452	454	GAC	203;209;209	G;A,G;C	193;194,1;199	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1514	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1228	122.5	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	632	634	CAC	184;185;188	C;A;C	173;172;176	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	800	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1109	72.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4306	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2823	151.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1567	1569	GCA	167;170;169	G;C,T,G;A	154;151,1,1;154	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4306	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2823	151.8	1	SNP	p	D86N	0	.	.	256	258	GAC	520	522	GAC	195;190;192	G;A;C	173;174;176	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4306	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2823	151.8	1	SNP	p	S87R	0	.	.	259	261	AGT	523	525	AGT	194;194;192	A,C;G;T	173,1;172;170	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4306	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2823	151.8	1	SNP	p	S87W	0	.	.	259	261	AGT	523	525	AGT	194;194;192	A,C;G;T	173,1;172;170	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4306	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2823	151.8	1	SNP	p	S87I	0	.	.	259	261	AGT	523	525	AGT	194;194;192	A,C;G;T	173,1;172;170	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4306	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2823	151.8	1	SNP	p	S88P	0	.	.	262	264	TCC	526	528	TCC	193;194;197	T;C;C	170;173;176	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4032	parE	1986	1986	99.95	parE.l6.c30.ctg.1	2737	146.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1550	1552	GGC	193;192;190	G;G;C	176;173;171	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1330	1332	GCA	210;208;207	G;C;A	190;188;193	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1333	1335	ATC	209;209;208	A;T;C	195;193;195	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1345	1347	GTG	204;203;203	G;T;G	192;191;190	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1345	1347	GTG	204;203;203	G;T;G	192;191;190	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1849	1851	ACC	185;187;185	A;C;C	166;172;171	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1903	1905	GCG	188;189;185	G;C;G	170;159;156	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1903	1905	GCG	188;189;185	G;C;G	170;159;156	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2026	2028	GGC	182;180;178	G;G;C	170;167;163	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2035	2037	GGC	178;180;184	G;G,A;C	163;162,1;166	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3804	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2565	148.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2053	2055	CTG	180;180;180	C,G;T;G	135,4;126;137	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5474	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3037	179.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1658	1660	CCG	200;200;202	C;C;G	181;187;180	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2132	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1597	132.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	448	448	C	142	C	136	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	1556	porB1a	984	984	94.02	porB1a.l15.c4.ctg.1	1332	115.3	0	.	p	.	0	T9A	NONSYN	25	27	ACT	248	250	GCT	126;126;126	G;C;T	120;122;122	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	1556	porB1a	984	984	94.02	porB1a.l15.c4.ctg.1	1332	115.3	0	.	p	.	0	A29V	NONSYN	85	87	GCC	308	310	GTC	138;136;137	G;T;C	129;128;126	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	1556	porB1a	984	984	94.02	porB1a.l15.c4.ctg.1	1332	115.3	0	.	p	.	0	A38D	NONSYN	112	114	GCT	335	337	GAT	130;132;130	G;A;T	126;127;122	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	1556	porB1a	984	984	94.02	porB1a.l15.c4.ctg.1	1332	115.3	0	.	p	.	0	.	MULTIPLE	115	117	TAC	338	341	CACA	131;130;130;127	C;A;C;A	124;122;123;122	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	1556	porB1a	984	984	94.02	porB1a.l15.c4.ctg.1	1332	115.3	0	.	p	.	0	H40fs	FSHIFT	118	118	C	342	342	C	127	C	123	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11162	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4987	223.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2064	2066	CAT	250;253;251	C;A;T	236;236;234	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1246	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1172	106.3	1	SNP	p	V57M	0	.	.	169	171	GTG	590	592	GTG	237;241;242	G,A;T;G	225,1;228;229	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
